India has so far administered 1,722,947,688 vaccine doses. That is 4045.75 per cent of its total caseload, and 122.97 per cent of its population
The tech spending in India is likely to grow 8.7 per cent in 2022, one of the highest growth rates in the Asia Pacific region, according to a new report.
The Central government on Saturday informed that more than 12.27 crores balance and unutilized vaccine doses are still available with States and UTs
The US FDA) announced that it has postponed an advisory panel meeting on the use of the Pfizer-BioNTech Covid-19 vaccine in children six months through four years of age, saying it needs more data.
Mansukh Mandaviya informed Lok Sabha genome sequencing of 84,386 cases of Covid Variants of Concern and 5,606 cases of Variants of Interest have been conducted in the country so far
The global coronavirus caseload has topped 408.1 million, while the deaths have surged to more than 5.80 million and vaccinations to over 10.16 billion, according to Johns Hopkins University.
Partners with Shilpa Medicare to manufacture vaccines, therapeutics
Thirteen instances of Adverse Event Following Immunization (AEFI) have been reported among lactating women till February 3 and all these cases were minor, Mansukh Mandaviya informed Lok Sabha
The highest number of 43 fatalities has been reported as AEFI from Kerala, followed by 15 from Maharashtra
As many as 2,612 persons tested positive for coronavirus, while three died of the infection in Madhya Pradesh in the last 24 hours, raising the tally to 10,21,361 and toll to 10,682
Only 1,116 of the 36,966 hospital beds earmarked for Covid treatment are currently occupied, the Brihanmumbai Municipal Corporation bulletin informed
The first batch of COVID-19 vaccines under the Quad initiative will be delivered in the first half of 2022, the foreign ministers of the coalition said on Friday
The data shows that less than 11 per cent of people have received at least one dose against Covid in low-income countries
The first batch of COVID-19 vaccines under the Quad initiative will be delivered in the first half of 2022, the foreign ministers of the grouping said
Scientists in the US have developed an inexpensive, non-toxic coating for almost any fabric that decreases the infectivity of SARS-CoV-2, the virus that causes COVID-19, by up to 90 per cent. The coating, described in the journal ACS Applied Materials & Interfaces, may be used in future to develop an antiviral spray for fabrics. "When you are walking into a hospital, you want to know that pillow you are putting your head onto is clean," said study lead author Taylor Wright, a doctoral student at the University of British Columbia (UBC) in Canada. "This coating could take a little bit of the worry off frontline workers to have personal protection equipment (PPE) with antimicrobial properties," Wright said. Researchers soaked fabric in a solution of a bacteria-killing polymer which contains a molecule that releases sterilising forms of oxygen when light shines on it. They then used an ultraviolet (UV) light to turn this solution to a solid, fixing the coating to the fabric. "This .
When an individual is infected with the Covid-19 causing virus SARS-CoV-2, the immune system is called into action to produce antibodies and T cells that target viral proteins and clear the infection.
India has so far administered 1,717,951,432 vaccine doses. That is 4038.8 per cent of its total caseload, and 122.61 per cent of its population
Thane's mortality rate is 1.67 per cent
The daily positivity rate has been recorded at 3.89 per cent while weekly positivity rate has been recorded at 5.76 per cent
The US has the highest cumulative number of confirmed cases and deaths